EGFR anticorps (C-Term)
Aperçu rapide pour EGFR anticorps (C-Term) (ABIN285758)
Antigène
Voir toutes EGFR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Immunogène
- EGFR antibody was raised in rabbit using a synthetic peptide corresponding to a region near the carboxy terminus which is identical in human, mouse and rat EGFR, as the immunogen.
-
-
-
-
Indications d'application
- ELISA: 1:10,000-1:50,000, IP: 2.5 μg/mL, WB: 1:1,000-1:10,000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Supplied as a liquid with 0.01 % NaN3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4 °C. Dilute only prior to immediate use
-
-
-
: "Cell adhesion and EGFR activation regulate EphA2 expression in cancer." dans: Cellular signalling, Vol. 22, Issue 4, pp. 636-44, (2010) (PubMed).
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Autre désignation
- EGFR
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Antigène
-